Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Neonatal Susceptibility and Immunity to Major Bacterial Pathogens [with Discussion]

Patricia Ferrieri
Reviews of Infectious Diseases
Vol. 12, Supplement 4. Neonatal Sepsis and the Role of Immunotherapy (May - Jun., 1990), pp. S394-S400
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4455579
Page Count: 7
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Neonatal Susceptibility and Immunity to Major Bacterial Pathogens [with Discussion]
Preview not available

Abstract

Neonatal bacterial sepsis has continued in this decade to contribute significantly to neonatal mortality and morbidity and is a critical determinant of outcome in infants of very low birth weight despite the availability of antibiotics. The group B Streptococcus and Escherichia coli are the predominant pathogens for the newborn infant. Studies on the epidemiology, microbiology, and immunology of group B streptococcal disease are more extensive than those on E. coli disease. Type-specific antibodies, polymorphonuclear leukocytes, and complement are integral to immunity against group B Streptococcus, and experimental data are presented to support the importance of these components. The newborn infant is handicapped by temporary deficiencies in host defenses, and approaches for restoring immunocompetence, such as immunization of the mother or passive administration of intravenous immunoglobulins or other immune factors, are presented for consideration. Further studies are required to demonstrate the safety, feasibility, and efficacy of these approaches.

Page Thumbnails

  • Thumbnail: Page 
S394
    S394
  • Thumbnail: Page 
S395
    S395
  • Thumbnail: Page 
S396
    S396
  • Thumbnail: Page 
S397
    S397
  • Thumbnail: Page 
S398
    S398
  • Thumbnail: Page 
S399
    S399
  • Thumbnail: Page 
S400
    S400